#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Multifocal motor neuropathy Angiosarcoma Hodgkin's disease Chemical burn Small for dates baby Immune-mediated myositis Urea cycle disorder Peritoneal mesothelioma malignant Pneumonia Primary immunodeficiency syndrome Glioblastoma multiforme Dent's disease CDKL5 deficiency disorder Peripheral T-cell lymphoma unspecified Gastroenteropancreatic neuroendocrine tumour disease More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy Acquired haemophilia – Life with Disease Haemophilia B without inhibitors – Life with Disease Fragile X syndrome – Treatment Kearns-Sayre syndrome Familial haemophagocytic lymphohistiocytosis – Basic Information Pulmonary sarcoidosis Systemic mastocytosis – Life with Disease Atypical haemolytic uraemic syndrome – Basic Information Alport’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Camonsertib Landiolol Hydrochloride Methadone Hydrochloride Bictegravir LVT-001 Amphotericine B, Liposome Pentosan Polysulfate Sodium Fianlimab Dabigatran Etexilate Pevonedistat LUMC-BOB1-B7-TCR.1 Pantoprazole Narsoplimab TIL CELLS GSKVX000000030810 Betamethasone Donidalorsen Ezabenlimab APAZUNERSEN Tafluprost More therapies…

    Learn about Your Condition

    Adrenoleukodystrophy Renal cell carcinoma Tubulointerstitial nephritis Metastases to lymph nodes Endolymphatic hydrops Cystic fibrosis Embolism Paraesthesia Endometrial cancer metastatic Ependymoma malignant Burning mouth syndrome Procedural haemorrhage Macular oedema Malignant melanoma stage IV Alveolar proteinosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of ipilimumab, nivolumab, temozolomide and capecitabine in patients with chemotherapy-resistant metastatic colorectal cancer with specific genetic markers

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Ipilimumab
    • Temozolomide
    • Capecitabine
    Denmark

  • Evaluation of Brain Inflammation Using 18F-DPA-714 PET Imaging in Patients with Intracerebral Hemorrhage

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    France

  • Study comparing oral and injectable nefopam in patients with acute rheumatologic pain to evaluate how the medication is processed by the body

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pain
    Investigated Drugs:
    • Nefopam Hydrochloride
    France

  • Study of prucalopride and escitalopram combination to improve treatment response in patients with major depressive disorder

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Escitalopram
    France

  • Study of Lebrikizumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis to Understand How the Medicine Works

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Lebrikizumab
    Germany

  • Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Zipalertinib
    • Carboplatin
    • Cisplatin
    Belgium France Germany Greece Italy The Netherlands +3
Previous Page
1 … 780 781 782 783 784 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!